EU Exit: End of Transition Period

Debate between James Murray and Michael Gove

Monday 13th July 2020 Commons Chamber

[Michael Gove]

I again thank my right hon. Friend for the role that he played in reconstituting the Northern Ireland Executive earlier this year, which of course has made the whole process of agreeing the approach towards the Northern Ireland protocol and safeguarding the rights of Northern Ireland citizens significantly easier. We should all be grateful for his leadership in that role, which helped advance the cause of peace. On the specific point about securing a comprehensive free trade agreement with the European Union, I am completely with him. I think that it would be better, as the hon. Member for Leeds West (Rachel Reeves) also mentioned, for us to have the zero-tariff, zero-quota approach that we can secure through a comprehensive FTA, but I should add that whether or not we secure that FTA, many of the steps that I have outlined today will be required by business as “no regrets” steps anyway.

[James Murray (Ealing North) (Lab/Co-op) [V]]

At the end of March, I was told by the Minister for Patient Safety, Mental Health and Suicide Prevention, the hon. Member for Mid Bedfordshire (Ms Dorries), that

“any European Union centrally authorised”

covid-19 vaccine would

“be authorised in the UK”

during the transition period, and that the Government were

“working to ensure that UK patients can access the best and most innovative medicines”

beyond 31 December 2020. Can the right hon. Gentleman now guarantee that, whatever else changes at the end of this year, there will be no risk of any delay after 31 December in the UK acquiring a covid-19 vaccine in comparison with countries in the EU?

[Michael Gove]

I am grateful to the hon. Gentleman for his question. It is the case that there is global collaboration through the CEPI programme to try to ensure that all countries that are determined to deal with the covid-19 threat can work together to develop a vaccine. We have relationships with European and other nations, which are there to ensure that we are in a strong position to be able to provide a vaccine for our citizens once one is effectively tested.

Public Services

Debate between James Murray and Michael Gove

Tuesday 28th April 2020 Commons Chamber

[Michael Gove]

My hon. Friend makes a very important point. The Lord Chancellor has ensured that we have a system in prisons where we effectively segment and isolate those who may have the virus. It is also the case that we have ensured that additional capacity has been sourced. There has also been a very targeted early release programme in order to ensure that we manage the estate appropriately.

[James Murray (Ealing North) (Lab/Co-op) [V]]

Community testing and contact tracing will be crucial to keep infection as low as possible in the months ahead. We need an effective system with local understanding of capacity. I am therefore very concerned that the Government’s plans for contact tracing seem to rely on a phone-based system with 18,000 staff who will all be recruited nationally. I learned last week that local authority staff in Ealing and elsewhere have not yet been asked to play a part. So will the Minister confirm today whether they will be asked to play a part in contact tracing, and if so, what role and by when?

[Michael Gove]

Contact tracing is vitally important. It should be done both through the new NHS app that is being developed and through those who are working at Public Health England, and others. But I will consider with the Health Secretary what additional steps may be required.